{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-24-000011","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.701985+00:00","generated_at":"2026-06-06T06:03:52.876043+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Tenet Q4 net income $244M, adj EBITDA $1.012B (+12.8% YoY); 2024 outlook $3.285-3.485B adj EBITDA","bullets":["Q4 GAAP diluted EPS $2.30 vs $0.92 YoY; adjusted diluted EPS $2.68 vs $1.96.","Ambulatory Care adj EBITDA $464M (+14.0% YoY) on 3.9% same-facility surgical case growth.","Completed sale of three SC hospitals to Novant Health for ~$2.4B on Feb 1; signed deal to sell four CA hospitals to UCI Health for ~$975M.","FY 2024 outlook: adj EBITDA $3.285B-$3.485B; net rev $19.9B-$20.3B; adj EPS $5.76-$6.90.","Q4 hospital segment adj EBITDA excl. grant income $546M vs $450M YoY; same-hospital non-COVID admissions +2.6%."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-24-000011","json":"https://secwatch.observer/filing/0000070318-24-000011.json","markdown":"https://secwatch.observer/filing/0000070318-24-000011.md","text":"https://secwatch.observer/filing/0000070318-24-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/thc-20240208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T06:03:52.876043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b59783169ebb2f70e90b1d725f55335af766a19","claim":"TENET HEALTHCARE CORP reported the quarter ended December 31, 2023 results: revenue $5,379, net income $244 million, EPS $2.30 per diluted share. Guidance raised.","evidence_excerpt":"2022 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Revenue","value":"$5,379"},{"label":"Net income","value":"$244 million"},{"label":"EPS","value":"$2.30 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e71b07ae5cb772ed5ca2d09456d186df44a6f6cc","claim":"TENET HEALTHCARE CORP reported the year ended December 31, 2023 results: revenue $20,548, net income $611 million, EPS $5.71 per diluted share. Guidance raised.","evidence_excerpt":"as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from continuing","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Revenue","value":"$20,548"},{"label":"Net income","value":"$611 million"},{"label":"EPS","value":"$5.71 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}